Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease-Reference-Cited by-同舟云学术

Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease

Published:2008-03-01 Issue:3 Volume:49 Page:219
ISSN:0885-4513
Container-title:Biotechnology and Applied Biochemistry
language:en
Short-container-title:Biotechnol. Appl. Biochem.

Author:

Natale Paola Di,Villani Guglielmo R. D.,Parini Rossella,Scarpa Maurizio,Parenti Giancarlo,Pontarelli Gianfranco,Grosso Michela,Sersale Giovanna,Tomanin Rosella,Sibilio Michelina,Barone Rita,Fiumara Agata

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MPS I: Early diagnosis, bone disease and treatment, where are we now?;Journal of Inherited Metabolic Disease;2021-09-15

2. Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidoses;Molecular Genetics and Metabolism;2020-08

3. Setup and Validation of a Targeted Next-Generation Sequencing Approach for the Diagnosis of Lysosomal Storage Disorders;The Journal of Molecular Diagnostics;2020-04

4. Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study;European Journal of Pediatrics;2019-02-26

5. Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in theARSBgene;Human Mutation;2018-09-17